(Reuters) – The U.S. Food & Drug Administration has approved Johnson & Johnson’s device for a type of condition which causes abnormal heart rhythm, the company said on Thursday. The device, Varipulse, is a pulsed field ablation system. Medical device makers such as Boston Scientific and Medtronic also have devices approved for atrial fibrillation, a […]
Health
US FDA approves Johnson & Johnson’s device for heart condition
Audio By Carbonatix
(Reuters) – The U.S. Food & Drug Administration has approved Johnson & Johnson’s device for a type of condition which causes abnormal heart rhythm, the company said on Thursday.
The device, Varipulse, is a pulsed field ablation system.
Medical device makers such as Boston Scientific and Medtronic also have devices approved for atrial fibrillation, a condition that is characterized by an irregular rhythm of the heart.
The health regulator has approved the use of the J&J device for the treatment of drug refractory paroxysmal atrial fibrillation, in which the symptoms are occasional and usually last between a few minutes and hours.
(This story has been corrected to remove the reference to the device’s mechanism in paragraph 2)
(Reporting by Sriparna Roy in Bengaluru; Editing by Shounak Dasgupta)